Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Kim

Showing results (81-90 of 103) with videos related to

Pageof 11
Sort By:
Hormones and Behavior|December 6, 2020
No evidence for a difference in 2D:4D ratio between youth with elevated prenatal androgen exposure due to congenital adrenal hyperplasia and controlsGideon Nave, Christina M Koppin, Dylan Manfredi, et al.
Medical Devices (Auckland, N.Z.)|January 16, 2013
Cost-effective therapeutic hypothermia treatment device for hypoxic ischemic encephalopathyJohn J Kim, Nathan Buchbinder, Simon Ammanuel, et al.
Cancer Research|October 7, 2004
JAGGED1 expression is associated with prostate cancer metastasis and recurrenceSandro Santagata, Francesca Demichelis, Alberto Riva, et al.
Cell Cycle (Georgetown, Tex.)|July 19, 2008
Caveolin-1 interacts with a lipid raft-associated population of fatty acid synthaseDolores Di Vizio, Rosalyn M Adam, Jayoung Kim, et al.
Neoplasia (New York, N.Y.)|September 3, 2009
RHAMM (CD168) is overexpressed at the protein level and may constitute an immunogenic antigen in advanced prostate cancer diseaseKilian M Gust, Matthias D Hofer, Sven R Perner, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 9, 2005
Decreased alpha-methylacyl CoA racemase expression in localized prostate cancer is associated with an increased rate of biochemical recurrence and cancer-specific deathMark A Rubin, Tarek A Bismar, Ove Andrén, et al.
Cancer Research|December 18, 2004
Androgen-independent prostate cancer is a heterogeneous group of diseases: lessons from a rapid autopsy programRajal B Shah, Rohit Mehra, Arul M Chinnaiyan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 19, 2006
Epidemiologic investigation of a cluster of workplace HIV infections in the adult film industry: Los Angeles, California, 2004Melanie M Taylor, Harlan Rotblatt, John T Brooks, et al.
Neoplasia (New York, N.Y.)|March 15, 2006
Defining aggressive prostate cancer using a 12-gene modelTarek A Bismar, Francesca Demichelis, Alberto Riva, et al.
Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B|May 5, 2012
Next-generation prostate cancer biobanking: toward a processing protocol amenable for the International Cancer Genome ConsortiumRaquel Esgueva, Kyung Park, Robert Kim, et al.
Pageof 11

Showing results (81-90 of 103) with videos related to

Sort By:
Pageof 11
Hormones and Behavior|December 6, 2020
No evidence for a difference in 2D:4D ratio between youth with elevated prenatal androgen exposure due to congenital adrenal hyperplasia and controlsGideon Nave, Christina M Koppin, Dylan Manfredi, et al.
Medical Devices (Auckland, N.Z.)|January 16, 2013
Cost-effective therapeutic hypothermia treatment device for hypoxic ischemic encephalopathyJohn J Kim, Nathan Buchbinder, Simon Ammanuel, et al.
Cancer Research|October 7, 2004
JAGGED1 expression is associated with prostate cancer metastasis and recurrenceSandro Santagata, Francesca Demichelis, Alberto Riva, et al.
Cell Cycle (Georgetown, Tex.)|July 19, 2008
Caveolin-1 interacts with a lipid raft-associated population of fatty acid synthaseDolores Di Vizio, Rosalyn M Adam, Jayoung Kim, et al.
Neoplasia (New York, N.Y.)|September 3, 2009
RHAMM (CD168) is overexpressed at the protein level and may constitute an immunogenic antigen in advanced prostate cancer diseaseKilian M Gust, Matthias D Hofer, Sven R Perner, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 9, 2005
Decreased alpha-methylacyl CoA racemase expression in localized prostate cancer is associated with an increased rate of biochemical recurrence and cancer-specific deathMark A Rubin, Tarek A Bismar, Ove Andrén, et al.
Cancer Research|December 18, 2004
Androgen-independent prostate cancer is a heterogeneous group of diseases: lessons from a rapid autopsy programRajal B Shah, Rohit Mehra, Arul M Chinnaiyan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 19, 2006
Epidemiologic investigation of a cluster of workplace HIV infections in the adult film industry: Los Angeles, California, 2004Melanie M Taylor, Harlan Rotblatt, John T Brooks, et al.
Neoplasia (New York, N.Y.)|March 15, 2006
Defining aggressive prostate cancer using a 12-gene modelTarek A Bismar, Francesca Demichelis, Alberto Riva, et al.
Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B|May 5, 2012
Next-generation prostate cancer biobanking: toward a processing protocol amenable for the International Cancer Genome ConsortiumRaquel Esgueva, Kyung Park, Robert Kim, et al.
Pageof 11